87 related articles for article (PubMed ID: 19596915)
1. Expression of JNK-interacting protein JIP-1 and insulin-like growth factor II in Wilms tumour cell lines and primary Wilms tumours.
Engström W; Granerus M
Anticancer Res; 2009 Jul; 29(7):2467-72. PubMed ID: 19596915
[TBL] [Abstract][Full Text] [Related]
2. The expression of the insulin-like growth factor II, JIP-1 and WT1 genes in porcine nephroblastoma.
Engström W; Granerus M
Anticancer Res; 2009 Dec; 29(12):4999-5003. PubMed ID: 20044608
[TBL] [Abstract][Full Text] [Related]
3. The JNK interacting protein JIP-1 and insulin like growth factor II genes are co-expressed in human embryonic tumours.
Engström W; Rising A; Grip S
Anticancer Res; 2005; 25(2A):1075-8. PubMed ID: 15868948
[TBL] [Abstract][Full Text] [Related]
4. Expression of JNK interacting protein JIP-1 is down-regulated in liver from mouse embryos with a disrupted insulin-like growth factor II gene.
Rohbe L; Larsson M; Rising A; Grip S; Burns J; Engström W
In Vivo; 2004; 18(5):643-7. PubMed ID: 15523906
[TBL] [Abstract][Full Text] [Related]
5. Expression of insulin-like growth factor-II mRNA in fetal kidney and Wilms' tumor. An in situ hybridization study.
Paik S; Rosen N; Jung W; You JM; Lippman ME; Perdue JF; Yee D
Lab Invest; 1989 Nov; 61(5):522-6. PubMed ID: 2554059
[TBL] [Abstract][Full Text] [Related]
6. Identification of small-molecule inhibitors of the JIP-JNK interaction.
Chen T; Kablaoui N; Little J; Timofeevski S; Tschantz WR; Chen P; Feng J; Charlton M; Stanton R; Bauer P
Biochem J; 2009 May; 420(2):283-94. PubMed ID: 19243309
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the insulin-like growth factor axis and Wilms' tumour suppressor gene in hyperparathyroidism.
Wong CK; Lai T; White S; Sheffield E; Wheeler MH; Stewart CE; Farndon JR
Br J Surg; 2007 Oct; 94(10):1232-41. PubMed ID: 17665418
[TBL] [Abstract][Full Text] [Related]
8. Effects of type I interferons on IGF-mediated autocrine/paracrine growth of human neuroendocrine tumor cells.
Vitale G; van Koetsveld PM; de Herder WW; van der Wansem K; Janssen JA; Colao A; Lombardi G; Lamberts SW; Hofland LJ
Am J Physiol Endocrinol Metab; 2009 Mar; 296(3):E559-66. PubMed ID: 19141687
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of Igf and Wnt signalling associated genes in pleomorphic adenomas of the salivary glands in PLAG1 transgenic mice.
Declercq J; Van Dyck F; Van Damme B; Van de Ven WJ
Int J Oncol; 2008 May; 32(5):1041-7. PubMed ID: 18425330
[TBL] [Abstract][Full Text] [Related]
10. Dietary carbohydrate source alters gene expression profile of intestinal epithelium in mice.
Wang B; Bobe G; LaPres JJ; Bourquin LD
Nutr Cancer; 2009; 61(1):146-55. PubMed ID: 19116885
[TBL] [Abstract][Full Text] [Related]
11. Insulin receptor isoform A and insulin-like growth factor II as additional treatment targets in human osteosarcoma.
Avnet S; Sciacca L; Salerno M; Gancitano G; Cassarino MF; Longhi A; Zakikhani M; Carboni JM; Gottardis M; Giunti A; Pollak M; Vigneri R; Baldini N
Cancer Res; 2009 Mar; 69(6):2443-52. PubMed ID: 19258511
[TBL] [Abstract][Full Text] [Related]
12. Effects of fasting on IGF-I, IGF-II, and IGF-binding protein mRNA concentrations in channel catfish (Ictalurus punctatus).
Peterson BC; Waldbieser GC
Domest Anim Endocrinol; 2009 Aug; 37(2):74-83. PubMed ID: 19446983
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor-2/mannose-6 phosphate receptors.
El-Shewy HM; Luttrell LM
Vitam Horm; 2009; 80():667-97. PubMed ID: 19251055
[TBL] [Abstract][Full Text] [Related]
14. [Insulin-like growth factor (IGF)-II in human hepatocarcinogenesis--a potential therapeutic target?].
Nussbaum T; Vreden S; Farsad M; Schirmacher P; Breuhahn K
Verh Dtsch Ges Pathol; 2005; 89():254-60. PubMed ID: 18035699
[TBL] [Abstract][Full Text] [Related]
15. Role of the JNK-interacting protein 1/islet brain 1 in cell degeneration in Alzheimer disease and diabetes.
Beeler N; Riederer BM; Waeber G; Abderrahmani A
Brain Res Bull; 2009 Oct; 80(4-5):274-81. PubMed ID: 19616077
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor I (IGF-I) is a more potent regulator of gene expression than insulin in primary human myoblasts and myotubes.
Palsgaard J; Brown AE; Jensen M; Borup R; Walker M; De Meyts P
Growth Horm IGF Res; 2009 Apr; 19(2):168-78. PubMed ID: 19010705
[TBL] [Abstract][Full Text] [Related]
17. Systemic effects of insulin-like growth factor-II produced and released from Wilms tumour tissue.
Ren-Qiu Q; Ruelicke T; Hassam S; Haselbacher GK; Schoenle EJ
Eur J Pediatr; 1993 Feb; 152(2):102-6. PubMed ID: 8383050
[TBL] [Abstract][Full Text] [Related]
18. Relative expression of cell growth regulatory genes insulin-like growth factors (IGF-1 and IGF-2) and their receptors (IGF-1R and IGF-2R) in somatic cell nuclear transferred (SCNT) and in vitro fertilized (IVF) pre-implantation buffalo embryos.
Pandey A; Singh N; Gupta SC; Rana JS; Gupta N
Cell Biol Int; 2009 May; 33(5):555-64. PubMed ID: 19281854
[TBL] [Abstract][Full Text] [Related]
19. High frequency of loss of allelic integrity at Wilms' tumor suppressor gene-1 locus in advanced breast tumors associated with aggressiveness of the tumor.
Gupta S; Joshi K; Wig JD; Arora SK
Indian J Cancer; 2009; 46(4):303-10. PubMed ID: 19749460
[TBL] [Abstract][Full Text] [Related]
20. Blockade of Wnt signaling inhibits angiogenesis and tumor growth in hepatocellular carcinoma.
Hu J; Dong A; Fernandez-Ruiz V; Shan J; Kawa M; Martínez-Ansó E; Prieto J; Qian C
Cancer Res; 2009 Sep; 69(17):6951-9. PubMed ID: 19690140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
